FDA Approves LEQEMBI IV Maintenance Dosing for Early Alzheimer’s Disease

Read more

FDA Grants Priority Review to Merck’s WELIREG for Advanced Pheochromocytoma and Paraganglioma

Read more

Pfizer’s BRAFTOVI Combination Regimen Demonstrates Improved Response in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer

Read more

AstraZeneca to Invest C$820M in Canada to Expand Global Hub and Clinical Delivery

Read more

AbbVie and Neomorph Partner to Develop Molecular Glue Degraders for Oncology and Immunology

Read more

Lupin Receives U.S. FDA Approval for Sacubitril and Valsartan Tablets

Read more

Tevogen Bio Expands AI Partnership with Microsoft to Advance PredicTcell on Azure

Read more

Zai Lab’s ZL-1310 Earns FDA Orphan Drug Designation for Small Cell Lung Cancer Treatment

Read more

Cellipont Bioservices to Manufacture Master Cell Bank for Secretome Therapeutics’ Lead Asset STM-01

Read more

Glox Therapeutics Secures Share of £3M Funding to Combat Antibiotic Resistance in Cystic Fibrosis

Read more